期刊文献+

动脉瘤性蛛网膜下腔出血致脑血管痉挛的治疗研究进展 被引量:17

下载PDF
导出
摘要 蛛网膜下腔出血(subarachnoid hemorrhage,SAH)是指脑底部或脑表面的病变血管破裂,血液直接流入蛛网膜下腔引起的一种临床综合征,约占急性脑卒中的10.0%[1]。SAH的最主要病因为颅内动脉瘤破裂,约占85.0%。脑血管痉挛(cerebral vasospasm,CVS)是动脉瘤性蛛网膜下腔出血致残、致死重要原因。目前关于造成CVS的发病机制的研究较多。
作者 曹辉 蒋正方
出处 《西南军医》 2015年第2期202-205,共4页 Journal of Military Surgeon in Southwest China
  • 相关文献

参考文献23

  • 1王硕.脑血管痉挛防治神经外科专家共识[J].中国卒中杂志,2008,3(5):356-362. 被引量:79
  • 2Molyneux AJ,Kerr RS,Birks J, et al. Risk of recurrent sub- arachnoid haemorrhage,death,or dependence and stan- dardised mortality ratios after clipping or coiling of an in- tracranial aneurysm in the International Subarachnoid An- eurysm Trial (ISAT):long-termfollow-up [J]. LancetNeu- rol, 2009, 8 (5) :427-433.
  • 3Maud A1, Rodriguez GJ2, Barboza MA. Endovascular treatment of intracranial aneurysms by interventional neu- rologists: first year single-center experience [ J]. J Vasc In- terv Neurol,2014,7 (2) : 13-16.
  • 4Zhu W, Tian YL, Zhou LF, et al. Treatment strategies forcomplex internal carotid artery (ICA) aneurysms:direct ICAsacrifice or combined with extracranial-to-intracranial bypass E J 1. World Neurosurg, 2011, 75 ( 3 -4) : 476-484.
  • 5Sanai N, Zador Z, Lawton MT. By pass surgery for com- plex brain aneurysms: an assessment of intracranial-intra- cranial bypass ~ J ]. Neurosurgery, 2009, 65 (4) :670-683.
  • 6Ott S, Jedlicka S, Wolf S, et al. Continuous selective in- tra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage [J]. Biomed Res Int, 2014, 2014:970741.
  • 7Gibson CL, Srivastava K, Sprigg N, et aI. Inhibition of Rho-kinase protects cerebral barrier from ischaemia- evoked injury through modulations of endothelial cell oxi- dative stress and tight junctions EJ~. J Neurochem, 2014, 129(5):816-826.
  • 8梅运涛,崔传举,李艾帆.法舒地尔治疗脑血管痉挛的疗效及安全性[J].广东医学,2014,35(1):135-137. 被引量:22
  • 9邢娟.法舒地尔联合尼莫地平治疗动脉瘤性蛛网膜下腔出血后脑血管痉挛的疗效[J].江苏医药,2014,40(1):100-101. 被引量:50
  • 10Wong GK, Poon WS, Chan MT, et al. IMASH Investiga- tors. Intravenous magnesium sulphate for aneurysmal sub- arachnoid hemorrhage (IMASH): a randomized, dou- ble-blinded, placebo-controlled, multicenter phase III trial EJ]. Stroke,2010,41 (5):921-926.

二级参考文献66

共引文献173

同被引文献136

  • 1张卫强,林华,周勇安,王云杰.基质金属蛋白酶-2和基质金属蛋白酶-9在非小细胞肺癌组织中的表达及临床意义[J].中国现代医学杂志,2006,16(6):833-835. 被引量:20
  • 2沈建康.脑血管痉挛的机制和防治[J].国际脑血管病杂志,2006,14(7):481-493. 被引量:48
  • 3Miller RD.米勒麻醉学[M]. 7版.北京:北京大学医学出版社,2011:2285 -2287,2785 -2797.
  • 4Konishi T. Brain oxidative stress as basic target of antioxidant traditional oriental medicines [J].Neurochem Res, 2009, 34(4): 711 -716.
  • 5Hunu R, Heinen A, Weber NC, et al. Hypergly- caemia blocks sevoflurane induced postcondition- ing in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial perme- ability transition pore [ J ]. Br J Anaesth, 2008, 100(4) : 465 -471.
  • 6Chrysostomou C, Schmitt CG. Dexmedetomi- dine: sedation, analgesia and beyond[J]. Expert Opin Drug Metab Toxicol, 2008,4(5) : 619 -627.
  • 7Menda F, Koner O, Sayin M, et al. Dexmedetomi- dine as an adjunct to anesthetic induction to at- tenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG [J].Ann Card Anaesth, 2010, 13(1): 16-21.
  • 8Oh SH, Lee JG, Na S J, et al. The effect of initial serum neuron-specific enolase level on clinical outcome in acute carotid artery territory infarc- tion[J]. Yonsei Med J, 2002, 43(3): 357-362.
  • 9Naeimi ZS, Weinhofer A, Sarahrudi K, et al. Predic- tive value of S100β protein and neuron specific-eno- lase as markers of traumatic brain damage in clini- cal use[J]. Brain Int J, 2006, 20(5): 463-468.
  • 10Tanskanen PE, Kytta JV, Randell TT, et al. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, trolled study [ J ] 658 -665. randomized and placebo-con- Br J Anaesth, 2006, 97 (5).

引证文献17

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部